National & International Grants

National & International Grants

Nationally Funded Projects 2019

Identifying the Ewing Sarcoma cell-of-origin by cross-species enhancer activity analysis

CCRI responsible principle investigator: Sarah Grissenberger (supervisor: Martin Distel)

Grant from the Austria Academy of Sciences (ÖAW) - DOC fellowship

Duration: 01/12/2019 to 31/05/2022

 

CD Laboratory for "Next generation CAR-T cells"

CCRI coordinator: Manfred Lehner

Christian Doppler Association - Christian Doppler Lab

Duration: 01/11/2019 to 31/10/2026

 

Detection and prognostic relevance of DUX4 rearrangements in childhood leukemia

CCRI responsible principal investigator: Sabine Strehl

Grant from the Austrian National Bank (OeNB), Jubiläumsfonds

Duration: 01/08/2019 to 31/01/2022

 

Find tumor immune evasion strategies by cellular barcoding

CCRI responsible principal investigator: Eva König

Grant from the Austrian Science Fund (FWF), Stand Alone Project

Duration: 15/03/2019 to 15/03/2023

 

Ultra-high-risk pediatric cancer - combinatorial drivers and therapeutic targets for precision medicine

CCRI responsible principal investigator: Sabine Taschner-Mandl

Grant from the Vienna Science and Technology Fund (WWTF) - Life Sciences 2018

Duration: 01/03/2019 to 28/02/2022

 

Targeting the Ewing sarcoma microenvironment to overcome resistance to therapy

CCRI responsible principal investigator: Eleni Tomazou

Grant from the Vienna Science and Technology Fund (WWTF) - Life Sciences 2018

Duration: 01/03/2019 to 28/02/2023

 

Analysis of temporal and spatial Ewing sarcoma tumor evolution during chemotherapy and validation of its clinical implication

CCRI responsible principal investigator: Eleni Tomazou

Grant from the Austrian National Bank (OeNB), Jubiläumsfonds

Duration: 01/09/2018 to 31/08/2021

 

Phylogenetic analysis of primary and disseminated tumor cells to reconstruct the metastatic route of relapsed neuroblastomas

CCRI responsible principal investigator: Reza Abbasi

Grant from the Ingrid Shaker Nessmann Krebsforschungsvereinigung (ISNK)  – Forschungsförderung 2018

Duration: 01/02/2018 to 31/01/2019

 

Platform supporting an integrated analysis of image and multiOMICs data based on liquid biopsies for tumor diagnostics (VISIOMICS)

Labdia Coordinator: Sabine Taschner-Mandl, Peter Ambros

Grant from the Austrian Research Promotion Agency (FFG), COIN Programme

Duration: 01/11/2017 to 31/12/2019

 

Role of stress granules in Ewing sarcoma susceptibility

CCRI responsible principal investigator: Heinrich Kovar

Grant from the Austrian Science Fund (FWF), Stand Alone Project

Duration: 01/06/2017 to 31/05/2020

 

Establishing a zebrafish disease model drug screening platform, (Danio4Can)

CCRI responsible principal investigator: Martin Distel

Grant from the Austrian Research Promotion Agency (FFG), R&D Infrastrukturförderung, 1st Call

Duration: 01/05/2017 to 31/05/2019

 

Ewing sarcoma – an enhancer disease?

CCRI responsible principal investigator: Eleni Tomazou

Grant from the Austrian Science Fund (FWF), Elise Richter Programme

Duration: 01/01/2016 to 31/12/2020

 

Permanent consequences in childhood Langerhans cell histiocytosis

CCRI responsible principal investigator: Milen Minkov

Grant from the Austrian National Bank (OeNB), Jubiläumsfonds

Duration: 01/09/2015 to 31/05/2019

Internationally Funded Projects 2019

Charting key molecules and mechanisms of human immune Dysregulation (iDysChart)

CCRI responsible principal investigator: Kaan Boztug

European Commission Grant - ERC-2018-COG

Duration 06/01/2019 to 31/05/2024

 

Childhood Leukemia: Overcoming distance between South America and Europe Regions (CLOSER) CCRI partner: Oskar Haas

Coordinator: Mireia Camos (Hospital Sant Joan de Déu de Barcelona)

European Commission Grant - H2020-SC1-2018

Duration: 01/01/2019 to 31/12/2023

 

European Joint Programme on Rare Diseases (EJP RD)

CCRI responsible principal investigator: Ruth Ladenstein

European Commission Grant - H2020-SC1-BHC-2018-2020

Duration: 01/01/2019 – 31/12/2023

 

Molecular mechanisms of melflufen in osteosarcoma cells (Oncopeptides)

CCRI responsible principal investigators: Thomas Lion, Konstantin Byrgazov

Oncopeptides Preclinical Grant

Duration: 01/01/2019 to 31/12/2019

 

Comprehensive heatmap for TKI-resistance of mutations in BCR-ABL1 kinase domain

CCRI responsible principal investigators: Thomas Lion, Konstantin Byrgazov

Incyte Corporation - Incyte open calls

Duration: 01/01/2019 to 31/03/2020

 

Developmental hierarchy in LCH

CCRI responsible principal investigator: Caroline Hutter

Histiocytosis Association Grant

Duration: 01/01/2019 to 31/12/2019

 

PRedictive In-silico Multiscale Analytics (PRIMAGE)

CCRI responsible principal investigator: Ruth Ladenstein

European Commission Grant – Call H2020-SC1-DTH-2018-2020

Duration: 01/12/2018 to 30/11/2022

 

Integrated European Network on cGvHD

CCRI responsible principal investigator: Anita Lawitschka

European Commission Grant – COST Action

Duration: 31/08/2018 to 30/08/2022

 

ERN-PAEDCAN-CEF-Telecom

CCRI Coordinator: Ruth Ladenstein

European Commission Grant – Call CEF-TC-2017-2

Duration: 01/05/2018 to 31/08/2019

 

ERN-PAEDCAN Partner: Paediatric Rare Tumours Network - European Registry (PARTNER)

CCRI responsible principal investigator: Ruth Ladenstein

European Commission Grant – Call CEF-TC-2017-2

Duration: 01/01/2018 to 31/12/2020

 

Paediatric Cancer European Reference Network (ERN PaedCan)

CCRI Coordinator: Ruth Ladenstein

Grant from the European Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)

Duration: 01/03/2017 to 28/02/2022

 

ITCC Pediatric Preclinical POC Platform (ITCCP4)

CCRI partner: Heinrich Kovar

Coordinator: Stefan Pfister (Deutsches Krebsforschungszentrum DKFZ, Germany)

European Commission Grant – H2020 Innovative Medicines Initiative

Duration: 01/01/2017 to 31/12/2021

 

Children’s Liver Tumour European Research Network (ChiLTERN)

CCRI partner: Heidrun Boztug

Coordinator: Keith Wheatley (University of Birmingham, UK)

European Commission Grant - H2020-PHC-2014-2015

Duration: 01/01/2016 to 31/12/2020

 

Optimized diagnostics for improved treatment stratification in invasive fungal diseases (FUNGITECT)

CCRI/Labdia Coordinator: Thomas Lion

European Commission Grant – FP7 Cooperation Project

Duration: 01/01/2014 to 31/01/2019

 

EURO EWING Consortium – International clinical trials to improve survival from Ewing sarcoma (EEC)

CCRI partner: Heinrich Kovar

Coordinator: Jeremy Whelan (University College London, UK)

European Commission Grant – FP7 Cooperation Project

Duration: 01/01/2014 to 30/09/2019